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Increased heme-oxygenase 1 expression in
mesenchymal stem cell-derived adipocytes
decreases differentiation and lipid accumulation
via upregulation of the canonical Wnt signaling
cascade
Luca Vanella1,2†, Komal Sodhi1†, Dong Hyun Kim1, Nitin Puri3, Mani Maheshwari1, Terry D Hinds Jr3, Lars Bellner4,
Dov Goldstein5, Stephen J Peterson4, Joseph I Shapiro1 and Nader G Abraham1*
Abstract
Introduction: Heme oxygenase (HO), a major cytoprotective enzyme, attenuates oxidative stress and obesity. The
canonical Wnt signaling cascade plays a pivotal role in the regulation of adipogenesis. The present study examined
the interplay between HO-1and the Wnt canonical pathway in the modulation of adipogenesis in mesenchymal
stem cell (MSC)-derived adipocytes.
Methods: To verify the role of HO-1 in generating small healthy adipocytes, cobalt protoporphyrin (CoPP), inducer
of HO-1, was used during adipocyte differentiation. Lipid accumulation was measured by Oil red O staining and
lipid droplet size was measured by BODIPY staining.
Results: During adipogenesis in vitro, differentiating pre-adipocytes display transient increases in the expression of
genes involved in canonical Wnt signaling cascade. Increased levels of HO-1 expression and HO activity resulted in
elevated levels of b-catenin, pGSK3b, Wnt10b, Pref-1, and shh along with increased levels of adiponectin (P < 0.05).
In addition, induction of HO-1 resulted in a reduction in C/EBPa, PPARg, Peg-1/Mest, aP2, CD36 expression and
lipid accumulation (P < 0.05). Suppression of HO-1 gene by siRNA decreased Wnt10b, pGSK3b and b-catenin
expression, and increased lipid accumulation. The canonical Wnt responsive genes, IL-8 and SFRP1, were
upregulated by CoPP and their expression was decreased by the concurrent administration of tin mesoporphyrin
(SnMP), an inhibitor of HO activity. Furthermore, knockdown of Wnt10b gene expression by using siRNA showed
increased lipid accumulation, and this effect was not decreased by concurrent treatment with CoPP. Also our
results show that blocking the Wnt 10b antagonist, Dickkopf 1 (Dkk-1), by siRNA decreased lipid accumulation and
this effect was further enhanced by concurrent administration of CoPP.
Conclusions: This is the first study to demonstrate that HO-1 acts upstream of canonical Wnt signaling cascade
and decreases lipogenesis and adipocyte differentiation suggesting that the HO-1 mediated increase in Wnt10b
can modulate the adipocyte phenotype by regulating the transcriptional factors that play a role in adipogenesis.
This is evidenced by a decrease in lipid accumulation and inflammatory cytokine levels, increased adiponectin
levels and elevation of the expression of genes of the canonical Wnt signaling cascade.
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Introduction
Human bone marrow-derived mesenchymal stem cells
(MSCs) are multipotent cells that have the potential to dif-
ferentiate into a variety of cell types including adipocytes
[1-5]. MSC-derived adipocyte differentiation and dysregu-
lation of adipogenesis is implicated in the pathogenesis of
diseases such as metabolic syndrome [4]. Enhanced adipo-
genesis with adipocyte hypertrophy is one of the leading
causes of adipose tissue hypoxia, inflammation, and dys-
function [6]. Hence, the elucidation of the mechanisms
that regulate commitment of MSCs towards adipogenic
fate may offer a portal to the development of treatment for
metabolic syndrome and its related vascular complications.
Adipogenesis begins with the commitment of MSCs to
the adipocyte lineage, followed by terminal differentiation
of pre-adipocytes to mature adipocytes [5,7]. Fat tissue-
derived adipocytes express several regulatory proteins
such as Wnts and b-catenin, as well as Sonic hedgehog
(Shh), which potentially works upstream of these known
differentiation factors to induce osteogenesis in MSCs
[8]. Wnts regulate gene expression through either the
canonical (b-catenin-dependent) or the non-canonical
(b-catenin-independent) pathway [9,10]. The canonical
Wnt signaling pathway controls cell proliferation, cell
survival and cell fate. Wnt ligands are secreted glycopro-
teins that function in a paracrine and autocrine manner.
Among the Wnt ligands identified, Wnt10b has been
shown to be a crucial factor in the activation of the
canonical pathway and inhibition of adipogenesis [11,12].
Adipose tissue-specific transgenic over-expression of
Wnt10b leads to a significant decrease in adiposity and
resistance to a high-fat diet in mice [13]. The canonical
Wnt pathway relies on stabilization of b catenin. The
Wnt/b catenin signaling pathway affects cellular func-
tions by regulating both b catenin levels and subcellular
localization [14].
An increase in Wnt/b-catenin signaling inhibits the adi-
pogenic transcription factor CCAAT/enhancer binding
protein (C/EBPa) and the peroxisome proliferator activa-
tor receptor (PPARg) [11,15-17]. Adipocyte differentiation
is an ordered multistep process requiring the sequential
activation of several groups of transcription factors,
including CCAAT/enhancer-binding protein (C/EBPa)
gene family and peroxisome proliferator activated recep-
tor-g (PPAR-g) [1,18]. C/EBPa and PPARg are involved in
the growth arrest that is required for adipocyte differentia-
tion. Pre-adipocyte factor-1 (Pref-1) belongs to the Notch
family of epidermal growth factor-like repeat-containing
proteins and has been shown to participate in maintaining
pre-adipose phenotype [19]. Pref-1 is an inhibitor of adi-
pocyte differentiation, hence a decrease in Pref-1 expres-
sion is observed during differentiation of adipocytes [20].
The paternally expressed 1 (Peg-1)/Mesoderm-specific
transcript (Mest) [21], when upregulated, results in the
enlargement of adipocytes during adipose tissue expansion
[22]. On accumulation of triglycerides, the levels of Peg-1/
Mest [22] are increased with a concomitant signal to pre-
adipocytes to enlarge in order to accommodate more tri-
glycerides. Adipocyte enlargement is associated with an
increase in the levels of TNFa, IL-1, IL-6 and increased
insulin resistance [23-26]. Hedgehog signaling exerts its
pleiotropic effects through regulation of the cell cycle,
direction of cell differentiation, and alteration of cell survi-
val [27]. Conversely, Shh signaling represses adipogenic
differentiation in pre-adipocytes [28].
Heme oxygenase-1 (HO-1) is a stress response gene cri-
tical for bone marrow cell differentiation [29-31]. A por-
phyrin structure within cyanocobalamine enables it to
induce HO-1 gene expression by facilitating its binding to
the porphyrin binding domain of the HO-1 gene. Induc-
tion of HO-1 enhances cell survival and moderates dia-
betes and obesity [32]. Induction of HO-1 gene expression
in vivo and in cell culture results in an increase in pre-adi-
pocytes, a reduction in the number of enlarged adipocytes,
and an increase in small adipocyte and adiponectin levels
[33]. A decrease in HO-1 expression results in increased
insulin resistance and adiposity in Zucker rats and obese
mice [34]. Additionally, induction of HO-1 in adipocyte
cell culture is associated with increased adiponectin levels
and decreased pro-inflammatory cytokines, TNFa and
IL-6 [35,36].
The goal of this study was to elucidate the role of HO-1
gene expression on adipogenesis and clarify the role of
Wnt10b and its dependent genes in this process. Induc-
tion of HO-1 gene expression and HO activity decreased
lipid deposition and inflammatory cytokine levels,
increased adiponectin levels and elevated the expression
of genes of the canonical Wnt signaling cascade. These
novel findings demonstrate that increased levels of HO-1
appear crucial in modulating the phenotype of adipocytes
to express canonical downstream signaling proteins.
Materials and methods
Differentiation of human bone marrow-derived MSCs into
adipocytes
Frozen bone marrow mononuclear cells were purchased
from Allcells (Allcells, Emeryville, CA, USA). After thaw-
ing, mononuclear cells were resuspended in an a-minimal
essential medium (a-MEM, Invitrogen, Carlsbad, CA,
USA) supplemented with 10% heat-inactivated FBS (Invi-
trogen) and 1% antibiotic/antimycotic solution (Invitrogen).
The cells were plated at a density of 1 to 5 × 106 cells per
100-cm2 dish. The cultures were maintained at 37°C in a
5% CO2 incubator and the medium was changed after 48 h
and every 3 to 4 days thereafter. When the MSCs were
confluent, the cells were recovered by the addition of
0.25% trypsin/ethylenediaminetetraacetic acid (EDTA)
(Invitrogen). MSCs (passage 2 to 3) were plated in a
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75-cm2 flask at a density of 1 to 2 × 104 cells and cultured
in a-MEM with 10% FBS for 7 days. The medium was
replaced with adipogenic medium, and the cells were cul-
tured for an additional 14 days as described previously [37].
Human MSCs, passage 3, were cultured in the presence of
the HO-1 inducer cobalt protoporphyrin (CoPP) (5 μM)
and with the HO activity inhibitor tin (Sn4+)-mesopor-
phyrin (SnMP) (5 μM), which were administered every
2 days.
HO activity measurement
Heme oxygenase activity was measured in hMSCs by car-
bon monoxide (CO) production in cellular homogenates.
Briefly, hMSCs were homogenized in Sucrose (255 mM)-
Tris hydrochloride (20 mM) buffer (pH 7.4) with NP-40
(1% w/v), EDTA (1 mM), phenylmethylsulfonyl fluoride
(PMSF) (1 mM) and mammalian protease inhibitor cock-
tail (5% v/v). After homogenization, samples were centri-
fuged, at 6000 × g for 30 minutes at 4°C, and the
supernatant collected for measurement of HO activity;
100 μg protein/sample was incubated, in gas-sealed vials,
in Sucrose-Tris buffer along with nicotinamide adenine
dinucleotide phosphate-oxidase (NADPH) (1 mM) and
excess heme (40 μM), in both the absence and the pre-
sence of SnMP (2 μM). Samples were incubated in a
water bath, in the absence of light, at 37°C for 60 min-
utes, after which, the HO reaction was stopped by placing
the samples in ice. CO generation was quantitated in the
headspace using gas chromatography/mass spectrometry
(GC/MS), as previously described [38], using C13O16 as
an internal standard. Results are expressed as HO-depen-
dent CO generation by subtracting the amount of CO in
the presence of SnMP. CO generated is expressed as
pmoles/mg protein/hour.
Effect of CoPP on adipogenesis
To measure the effect of increased HO-1 expression on
MSC-derived adipocyte differentiation, cells were treated
with 0.5, 1.0, 2.0, 5.0, and 10.0 μM of CoPP every 4 days.
After 14 days, cells were stained with Oil Red O solution.
Oil Red O staining
Staining was performed using 0.21% Oil Red O in 100%
isopropanol (Sigma-Aldrich, St. Louis, MO, USA). Briefly,
adipocytes were fixed in 10% formaldehyde, stained with
Oil Red O for 10 minutes, rinsed with 60% isopropanol
(Sigma-Aldrich), and the Oil Red O eluted by adding
100% isopropanol for 10 minutes and the optical density
(OD) measured at 490 nm, for 0.5 sec reading.
Measurement of lipid droplet size
After induction of adipogenesis, lipid droplets were
stained with 2 μM boron-dipyrromethene (BODIPY)
493/503 (Molecular Probes, Eugene, OR, USA) [39]. Cell
size was measured using an ImagePro Analyzer (Media-
Cybernetics, Inc., Bethesda, MD, USA). The classification
of the size of lipid droplets was based on size by area
(pixels).
Cell viability test by lactic dehydrogenate assay (LDH)
We followed the manufacturer’s protocol (LDH Assay
kit, Cayman, Ann Arbor, MI, USA). Briefly, hMSC and
adipocytes at day 14 were plated in 96-well plates for
1 day. Next day, cell layers were washed twice with PBS,
and then cells were treated with various concentrations
of CoPP (0 to 10 μM). After incubation for 24 h, and
addition of 100 μl of reaction mixture to each well, cells
were incubated for 4 hours at 37°C and 5% CO2 in a
humidified incubator. Absorbance was measured in the
96-well microplate using a microplate reader at 490 nm
with 650 nm as the reference wavelength, and the per-
centage of LDH release for each sample was normalized
according to the absorbance reading from samples trea-
ted with 0.5% Triton X-100. All analyses were replicated
eight times.
Cytokine array and adiponectin
TNFa and adiponectin (high molecular weight, HMW),
were measured as previously described [25,40] by Cyto-
kine SearchLight Infrared arrays (Pierce Biotechnology,
Inc., Woburn, MA, USA).
HO-1 siRNA transfection
Cells were treated with three different predesigned
siRNAs of the HO-1 gene (SASI_ Hs01_00035068,
SASI_Hs01_00035065 and SASI_Hs01_00035067 from
Sigma-Aldrich, St. Louis, MO, USA). According to the
manufacturer’s protocol, adipogenic media containing
siRNA using NTER (Sigma-Aldrich) was replaced every
48 h. Briefly, a nanoparticle solution was incubated with
10 nM siRNA. After 20 minutes cells were treated with
siRNA solution during adipogenesis, which was halted
after 10 days.
Measurement of MSC-derived adipocyte signaling
molecules
Cells were maintained at -80°C until required for assay.
Frozen cells were pulverized and placed in a homogeniza-
tion buffer (10 mM phosphate buffer, 250 mM sucrose,
1 mM EDTA, 0.1 mM PMSF and 0.1% tergitol, pH 7.5).
Homogenates were centrifuged at 27,000 × g for 10 min-
utes at 4°C. The supernatant was isolated and protein
levels were assayed (Bradford Method). The supernatant
was used for measurement of HO-1, Wnt10b, b-catenin,
Pref-1, C/EBPa, Peg-1/Mest, pGSK3b, shh, PPARg and
b-actin levels as described previously [25,41]. b-Actin
was used to ensure adequate sample loading for all
western blots.
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Quantitative real-time PCR analysis
Total RNA was extracted from differentiated human
mesenchymal stem cells using 5-Prime PerfectPure RNA
Tissue Kit (Fisher Scientific Company, LLC, Wilmington,
DE, USA). Total RNA was read on a NanoDrop 2000
spectrophotometer (Thermo Fisher Scientific) and cDNA
was synthesized using High Capacity cDNA Reverse-
Transcription Kit (Life Technologies, Grand Island, NY,
USA). PCR amplification of the cDNA was performed by
quantitative real-time PCR using TrueAmp SYBR Green
qPCR SuperMix (Smart Bioscience, Philadelphia, USA).
The thermocycling of IL-8 and Secreted frizzled-related
protein 1 (SFRP1) protocol consisted of 5 minutes at
95°C, 40 cycles of 15 sec at 95°C, and 30 sec at 60°C, and
finished with a melting curve ranging from 60 to 95°C to
allow distinction of specific products. Normalization was
performed in separate reactions with primers to 18S
mRNA (TTC GAACGTCTGCCCTATCAA and ATGG
TAGGCACGGCGACTA).
Statistical analyses
Statistical significance (P < 0.05) of differences between
experimental groups was determined by the Fisher
method for analysis of multiple comparisons. For com-
parison between treatment groups, the null hypothesis
was tested by either single-factor analysis of variance
(ANOVA) for multiple groups, or the unpaired t-test for
two groups, and the data are presented as mean ± stan-
dard error (SE).
Results
The effect of adipogenesis on HO-1 expression
The temporal sequence of HO-1 expression was deter-
mined over a 14-day period in MSC-derived adipocytes.
The basal levels of HO-1 expression increased during
MSC adipogenic culture growth and peaked at day 3
(Figure 1B). This was followed by gradual decrease in HO-
1 expression, while lipid droplet area gradually increased
over a period of 14 days (Figure 1A).
The effect of CoPP on cell viability during adipogenesis
by LDH assay
Detection of cell membrane integrity is a rapid and simple
approach to determine cell viability by measuring cellular
LDH leakage in damaging cells. Our results showed that
CoPP treatment in MSCs and adipocytes at day 14 have
no cytotoxic effects at concentrations up to 5 μM (Figure
1C). However, MSCs and adipocytes showed significant
toxicity at a 10 μM concentration of CoPP (P < 0.05).
The effect of CoPP on HO-1 expression, HO activity and
cytokine levels during adipogenesis
We examined the effect of CoPP on lipid accumulation
after 14 days, using standard culture conditions by
measuring Oil Red O-stained lipid droplet area (Figure
2A). The level of cells with Oil Red O-stained lipid dro-
plets decreased as CoPP concentration increased. CoPP
decreased lipid accumulation in a concentration-depen-
dent manner. Oil Red O staining was barely detectable at
the highest concentration of CoPP (10 μM), although
untreated MSC-derived adipocyte progenitor cells were
loaded with lipid droplets (control). Quantification of Oil
Red O-stained cells showed an increase in the number of
adipocytes in the absence of CoPP (77,093 ± 943 pixels)
compared with the presence of CoPP (54,376 ± 5,366 and
3,526 ± 368 pixels) at 1 and 10 μM, respectively. The
expression of HO-1 in the presence of CoPP increased in
a dose-dependent manner (Figure 2B), which was consis-
tent with our results showing decreased lipogenesis with
increased concentrations of CoPP (Figure 2A). HO activ-
ity, as measured by CO release, was increased in the
presence of CoPP compared to the control (Figure 2C;
P < 0.05). HO activity increased reaching a maximum
(P < 0.05) at day 10 and remained elevated. This was in
contrast to the control where HO activity remained at
the same level as day 0. One possible explanation of this
discrepancy between HO-1 expression and HO activity
could be differential effects of progressing adipogenesis
on HO-1 expression and activity. Other investigators
[42,43] have reported redox imbalances during the
process of adipogenesis. We have previously shown that
oxidative stress can induce HO expression while suppres-
sing HO activity [44] (Figure 2C).
Adipose cell enlargement is associated with increased
secretion of cytokines, which impairs the differentiation of
pre-adipocytes and reduces adiponectin secretion. We
examined the levels of TNFa in the conditioned media of
CoPP-treated MSC-derived adipocytes, and found that
TNFa levels were significantly decreased (Figure 2D; P <
0.001) at day 14. In contrast, CoPP increased adiponectin
levels were increased subsequent to CoPP treatment when
compared to controls at day 14 (P < 0.05; Figure 2E).
Effect of CoPP and SnMP on adipogenesis and
distribution of lipid droplet size, stained by BODIPY
After 14 days, the number of lipid droplets stained with
Oil Red O was lower after CoPP treatment when com-
pared to control (P < 0.05; Figure 3A-B). In contrast, HO
activity inhibitor, SnMP treatment, resulted in higher
levels of Oil Red O staining when compared to control
(Figure 3A-B). To confirm that increased levels of HO-1
resulted in decreased lipid accumulation, we stained lipid
droplets with BODIPY/4’,6-diamidino-2-phenylindole
(DAPI) (Figure 3C). CoPP treatment decreased the num-
ber of very large lipid droplets (P < 0.05) and increased
the number of small lipid droplets when compared with
control (Figure 3D). In contrast, SnMP significantly
increased the number of large lipid droplets (P < 0.05)
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and decreased the number of small lipid droplets, com-
pared with either culture treated with CoPP or control,
indicating that this effect is mediated by increased HO
activity (Figure 3D). The results were quantified and are
shown in Figure 3E.
Effect of CoPP and SnMP on CD36 expression
CD36, a fatty acid translocase, which mediates the trans-
fer of fatty acids (FAs) into the cell [45], was measured in
MSCs and MSC-derived adipocytes treated with either
CoPP (5 μM) or SnMP (5 μM). Cells were treated with
adipogenic media and collected after 14 days. As seen in
Figure 4A, during lipogenesis CoPP decreased CD36
expression (25.21 ± 1.67%) compared to control (44.29 ±
4.33%), while SnMP increased CD36 expression (52.83 ±
3.12%). The results are quantified in Figure 4B and show
that CoPP decreased CD36 levels (P < 0.05) compared to
control indicating decreased fatty acid uptake in adipo-
cytes by upregulation of HO-1. As expected, SnMP
restored CD36 levels to those seen in control, suggesting
that increased HO-1 expression and activity has anti-adi-
pogenic response on adipocytes.
Effect of siRNA HO-1 on adipogenesis
Upregulation of HO-1 by CoPP decreased lipid accumula-
tion, which was measured as the relative absorbance of Oil
Red O. To selectively assess the role of HO-1 on adiposity,
HO-1 siRNA was added to the cell culture. Lipid accumu-
lation was increased after HO-1 siRNA treatment as com-
pared to MSCs treated with CoPP (Figure 5A; P < 0.05).
Densitometry analysis showed that CoPP treatment
increased HO-1 expression in MSC-derived adipocytes
compared to the control, and this effect was reversed by
siRNA HO-1 (Figure 5B; P < 0.01). The protein expression
of Shh increased with CoPP treatment and was reversed
by siRNA HO-1 (Figure 5C). Pref-1, an excellent marker
for pre-adipocytes, which is extinguished during adipocyte
differentiation [19], was increased by CoPP treatment and
was decreased by siRNA HO-1 (Figure 5G). Upregulation
of HO-1 by CoPP treatment decreased levels of the
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adipogenic markers Peg-1/Mest, aP2, C/EBPa and PPARg
in MSC-derived adipocytes, and this effect was reversed by
transduction with HO-1 siRNA (Figure 5D, E, E, G and
5H respectively; P < 0.02).
Effect of siRNA HO-1 on canonical Wnt signaling and
Wnt-responsive genes
Upregulation of HO-1 by CoPP treatment increased
protein expression of the canonical Wnt signaling cas-
cade, Wnt10b, pGSK3b and b-catenin in MSC-derived
adipocytes as compared to the control. To selectively
assess the role of HO-1 on adiposity, HO-1 siRNA was
added to cell culture with a resultant decrease in
Wnt10b, pGSK3b and b-catenin levels (Figure 6A, B
and 6C respectively; P < 0.05). Canonical Wnt signaling
cascade is known to activate IL-8 and SFRP1 [46]. The
levels of these Wnt responsive genes, IL-8 and SFRP1,
were increased by CoPP treatment and these effects
were reversed by concurrent treatment with SnMP
(Figure 6D and E respectively; P < 0.05).
Effect of CoPP on canonical Wnt signaling cascade during
adipogenesis
Our results show Oil Red O staining was increased after
siRNA HO-1 treatment compared to MSCs treated with
CoPP (Figure 7A). To elucidate the role of Wnt10b in the
regulation of adipogenesis in MSC-derived adipocytes, we
measured the effect of suppression of Wnt10b on adipo-
genesis, using siRNA. The addition of siRNA Wnt10b
increased lipid formation compared to the vehicle (P <
0.05), and this effect was not significantly altered by con-
current administration of CoPP, suggesting a possible
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interaction between HO-1 and the Wnt10b pathway. Wnt
antagonist, Dickkopf 1 (Dkk1), is secreted by human pre-
adipocytes and promotes adipogenesis [47]. Further our
results show that knockdown of Wnt antagonist Dkk1 by
siRNA showed significant reduction in lipid accumulation
compared to siRNA Wnt10b, and more importantly,
administration of CoPP further significantly deceased lipo-
genesis (P < 0.05; Figure 7A).
The protein expression of b-catenin and phosphory-
lated glycogen synthase kinase (GSK3)b was measured
to study the effect of Wnt10b inhibition by using siRNA
(Figure 7B and 7C respectively). Our results showed
decreased expression of b-catenin and pGSK3b when
MSCs were treated with Wnt10b siRNA compared to
the control (P < 0.05) and this effect was not reversed
by concurrent treatment with CoPP. We next deter-
mined whether inhibition of Dkk1 using siRNA affected
these adipogenic markers. Our results further showed
that b-catenin and pGSK3b levels were increased com-
pared to the MSCs treated with siRNA Wnt10b. More
importantly, concurrent administration of CoPP signifi-
cantly increased the gene expression of b-catenin and
pGSK3b (P < 0.05) compared to the cells treated with
siRNA Dkk1.
Discussion
This study demonstrates that the effects of HO-1 induc-
tion in a cell-based model of adipogenesis are dependent
upon activation of the Wnt canonical signaling pathway.
HO-1 induction has reduced body weight and adiposity
[25,48] and improved the metabolic profile in animal mod-
els of obesity [24,49]. It has also been shown that upregu-
lation of HO-1 reduces adipogenesis in cell cultures [34].
We show here in a cell-based model of adipogenesis
(MSCs) that HO-1 induction mediates the recruitment of
the Wnt canonical cascade, and entails reduced lipid accu-
mulation comprised of smaller healthier adipocytes,
reduced inflammation and improved adipokine secretion.
Differentiation of pre-adipocytes into adipocytes is
regulated by a balance of transcriptional factors that can
both positively and negatively influence differentiation.
This is reflected by the appearance of various early, inter-
mediate and late mRNA/protein markers and triglyceride
accumulation. Several reports describe an association
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between adipogenesis and Wnt signaling in the regula-
tion of adult tissue homeostasis and remodeling [50,51].
Wnt10b is an endogenous regulator of adipogenesis that
maintains pre-adipocytes in an undifferentiated state and
functions as an adipogenic switch. The activation of
Wnt10b contributes to the inactivation/phosphorylation
of GSK3b and consequently, elevated level of b-catenin;
it is the molecular node of the canonical Wnt signaling
pathway. When Wnt signaling is active, GSK3 is inhib-
ited. Conversely, when Wnt signaling is suppressed,
GSK3 phosphorylates b-catenin and targets it for ubiqui-
tin-mediated degradation [11]. Our results describe a cri-
tical link between the anti-adipogenic effects of HO-1
and stimulation of the Wnt canonical pathway. Two lines
of evidence characterize this relationship: First, HO-1
induction in CoPP-treated cells was accompanied by
increased levels of Wnt10b and its associated signaling
mediators, namely, phosphorylated GSK3b and b-catenin.
The concurrent reduction in adipocyte size and lipid
accumulation establishes a link between this phenotype,
that is, HO-1 induction and Wnt signaling. Second,
siRNA-mediated downregulation/inhibition of Wnt10b
prevented HO-1 from reducing adipocyte hypertrophy in
MSCs. Further our results show that inhibition of Dkk1
by siRNA decreased lipogenesis, and this effect was
further enhanced by concurrent administration of CoPP.
These observations indicate that activation of the Wnt
canonical pathway plays a role in the prevention of adi-
pocyte hypertrophy and the promotion of smaller heal-
thier adipocytes in MSCs undergoing HO-1 induction.
The precise molecular mechanism linking HO-1 to acti-
vation of Wnt signaling is unclear. However, the restora-
tion of the redox environment as a result of HO-1
induction [37] could contribute to activation of Wnt sig-
naling. In this regard, it should be noted that chronic oxi-
dative stress has been shown to suppress the Wnt
canonical pathway [52,53] while enhancing lipid accumu-
lation and hypertrophy in MSC-derived adipocytes.
Furthermore, our studies show that upregulation of HO-
1and increased HO activity lead to increased levels of the
Wnt-responsive genes, IL-8 and SFRP1, which was
reversed by the HO-1 inhibitor, SnMP. Thus, these
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results substantiate our hypothesis that Wnt10b may be
considered an HO-1 gene target that when increased, ulti-
mately results in a reduction in adipocyte hypertrophy.
Activation of Wnt/b-catenin signaling maintains pre-
adipocytes in an undifferentiated state through inhibition
of the adipogenic transcription factors, C/EBPa and
PPARg [15-17]. C/EBPa and PPARg have been shown to
activate adipocyte-specific genes and are involved in the
growth arrest that is required for adipocyte differentiation.
Our results show that the increased expression of HO-1
resulted in either maintaining pre-adipocytes in the undif-
ferentiated state or slowed down this process, presumably
through activation of Wnt/b-catenin and inhibition of C/
EBPa and PPARg levels. Pref-1 has also been shown to
participate in maintaining the pre-adipose phenotype.
A decrease in Pref-1 expression is observed during adipo-
cyte differentiation. In adipose tissue, Pref-1 is specifically
expressed in pre-adipocytes but not in adipocytes and
thus, is used as a pre-adipocyte marker [54]. In concor-
dance with these observations, our results showed that
upregulation of HO-1 increased Pref-1 expression, sug-
gesting that HO-1 decreased adipocyte differentiation.
Pref-1 prevents lipid accumulation and expression of adi-
pocyte transcription factors such as PPARg and C/EBPa,
as well as other late adipocyte markers, including FA
synthase and FABP4/aP2 [54]. CD36 and aP2 are PPARg
target genes and their mRNA levels were significantly
increased during adipocyte differentiation, leading to
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increased lipid storage and lipogenesis [55]. Lipid accumu-
lation of avian adipocytes is mainly dependent upon the
FA transmembrane uptake process mediated by mem-
brane proteins, such as fatty acid translocase (FAT/CD36)
[45]. Our studies show that increased HO-1 gene expres-
sion decreased aP2 and CD36 levels, suggesting that HO-1
mediated increase of Wnt10b could inhibit fatty acid accu-
mulation and lipogenesis. Our study also showed that
upregulation of HO-1 is associated with increased adipo-
nectin levels and decreased inflammatory cytokine, TNFa.
Increased pro-inflammatory and reduced anti-inflamma-
tory cytokines reflect the functional consequences of upre-
gulation of HO-1 in MSC-derived adipocytes [34]. Smaller
adipocytes are considered to be healthy, insulin-sensitive
adipocytes that are capable of producing adiponectin [48].
In light of this evidence, elevation of adiponectin along
with suppression of TNFa synthesis by adipocytes cul-
tured in the presence of HO-1 induction complements the
effect of the latter on adipocyte size. Together, these find-
ings implicate the role of HO-1-Wnt signaling in bringing
about reduced lipid accumulation and improved adipocyte
function in MSC-derived adipocytes. Wnts, b-catenin and
Shh, are essential to regulate the conversion of pre-adipo-
cytes to adipocytes [16,47]. In this regard, we also exam-
ined Shh, which potentially works upstream of these
known differentiation factors to reduce adipogenesis [8,27].
Upregulation of HO-1 increased Shh protein expression,
which was reversed by siRNA of HO-1, confirming its role
in decreasing adipocyte hypertrophy.
Our results show that the increase in Wnt10b in parallel
with the increase in HO-1 gene expression by CoPP
was associated with a significant reduction in levels of
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Peg-1/Mest. A decrease in Peg-1/Mest is beneficial in the
control of obesity, since upregulation of Peg-1/Mest
occurs in obese adipose tissue in several models of obesity
[21,56]. Our data demonstrate that the induction of HO-1
was effective in suppressing adipocyte differentiation, as
evidenced by an increase in the canonical Wnt cascade
and a decrease in Peg-1/Mest. These effects were reversed
by blocking HO-1 gene expression by siRNA, further
demonstrating that HO-1 mediated-increase in Wnt10b,
and decrease in Peg-1/Mest resulted in the maintenance
of pre-adipocytes in their undifferentiated state with the
slowing of the differentiation process. Taken together,
these observations provide compelling evidence that HO-
1-mediated increase in Wnt signaling and its associated
genes modulate adipogenesis.
Conclusions
In conclusion, as represented in the schematic (Figure 8),
our novel study demonstrates that upregulation of HO-1
gene expression and increased HO activity decreased adi-
pocyte differentiation, with an associated increase in the
number of small healthy lipid droplets via interplay of the
Wnt signaling cascade. This is evident by the fact that
increased HO-1 expression and HO activity decreased adi-
pocyte hypertrophy, decreased TNFa levels, increased adi-
ponectin level and increased expression of the genes
central to the canonical Wnt signaling cascade. Thus,
crosstalk between HO-1 and Wnt10b could be employed
therapeutically to suppress adipogenesis, and therefore
constitutes an attractive drug development target to com-
bat obesity-associated metabolic complications.
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